专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2007124110A3 VASODIALATING DRESSING FOR USE WITH INTRAVENOUS CATHETERS 审中-公开
标题翻译： VASODIALATING DRESSING用于内窥镜
公开(公告)号：WO2007124110A3
公开(公告)日：2008-12-04
申请号：PCT/US2007009756
申请日：2007-04-19
申请人： CURE THERAPEUTICS INC , ANG ROBERT , GELIEBTER DAVID
发明人： ANG ROBERT , GELIEBTER DAVID
IPC分类号： A61F13/02 , A61F13/00 , A61M29/00
CPC分类号： A61L15/44 , A61K31/21 , A61L15/58 , A61L2300/204 , A61L2300/40 , A61L2300/602
摘要： The present invention is drawn to adhesive dressings and associated systems and methods for use in reducing the occurrence of phlebitis and extending the lifespan of intravenous catheters. The adhesive dressings can include a backing layer, and a nitroglycerin-containing composition supported at least in part by the backing layer. The adhesive dressing can have a drug delivery zone defined by the area where the nitroglycerin-containing composition contacts an intact human skin site. The drug delivery zone can have an area of at least 2.5 cm2 and can be configured such that when the adhesive dressing is applied to secure an intravenous catheter the drug delivery zone substantially overlays a vessel in which the intravenous catheter is inserted. The nitroglycerin-containing composition can be formulated to deliver nitroglycerin at from about 5 µg/hour to about 80 µg/hour.
摘要翻译：本发明涉及用于减少静脉炎发生并延长静脉内导管的寿命的粘合剂敷料和相关系统和方法。粘合剂敷料可以包括背衬层和至少部分由背衬层支撑的含有硝酸甘油的组合物。粘合敷料可以具有由含硝酸甘油的组合物接触完整的人皮肤部位的区域限定的药物递送区域。药物递送区可以具有至少2.5cm 2的面积，并且可以构造成使得当施加粘合剂敷料以固定静脉内导管时，药物递送区基本上覆盖其中插入静脉内导管的血管。含硝酸甘油的组合物可配制成以约5μg/小时至约80μg/小时递送硝酸甘油。

2. 发明申请

WO2007100910A3 TRANSDERMAL PATCHES CONTAINING A NITRIC OXIDE-DONOR AND A SECOND ACTIVE AGENT AND ASSOCIATED METHODS 审中-公开
公开(公告)号：WO2007100910A3
公开(公告)日：2007-09-07
申请号：PCT/US2007/005395
申请日：2007-02-28
申请人： CURE THERAPEUTICS, INC. , ANG, Robert , JACOBSON, Sven , WEIMMAN, Ludwig , MURRELL, George, Anthony, Calvert , GELIEBTER, David
发明人： ANG, Robert , JACOBSON, Sven , WEIMMAN, Ludwig , MURRELL, George, Anthony, Calvert , GELIEBTER, David
IPC分类号： A61F13/00
摘要： The present invention is drawn to a transdermal patch for the delivery of a nitric oxide-donor and a second active agent. The patch can comprise a backing layer and an active agent-containing composition which is supported at least in part by the backing layer. The active agent-containing composition can include an amount of a nitric oxide-donor and an amount of a second active agent. The transdermal patch can have a drug delivery zone defined by the area where the composition contacts an intact human skin site, and the transdermal patch can be formulated to deliver a nitric oxide donor, such as nitroglycerin, at from about 5 μg/hour to about 85 μg/hour. The second active agent can be selected from a number of agents including NSAIDS, opioids, local anesthetics, menthol, salicylic acid, salicylic acid derivatives, vanilloid receptor-1 activators, corticosteroids, vasoconstrictors, and combinations thereof.

3. 发明申请

WO2008027203A3 MEDICATED ORTHOPEDIC SUPPORT STRUCTURES FOR TREATMENT OF DAMAGED MUSCULOSKELETAL TISSUE 审中-公开
标题翻译：用于治疗损伤的胶质细胞组织的药物治疗支持结构
公开(公告)号：WO2008027203A3
公开(公告)日：2008-11-06
申请号：PCT/US2007018199
申请日：2007-08-14
申请人： CURE THEREPAUTICS INC , ANG ROBERT , WEIMANN LUDWIG , MURRELL ANTHONY CALVERT
发明人： ANG ROBERT , WEIMANN LUDWIG , MURRELL ANTHONY CALVERT
IPC分类号： A61F13/00
CPC分类号： A61K9/7061 , A61K31/21
摘要： A system and method for treating damaged musculoskeletal tissue includes an orthopedic support structure and a nitroglycerin-containing composition. The orthopedic support structure provides mechanical support to the damaged tissue and maintains the nitroglycerin-containing composition in contact with the skin of a subject wearing using the system. The nitroglycerin- containing composition can be integrated into the orthopedic support structure or the support structure can be configured to contain removable doses of the nitroglycerin-containing composition. The system and method provides relief of pain and improved function of the musculoskeletal tissue.
摘要翻译：用于治疗损伤的肌肉骨骼组织的系统和方法包括矫形支撑结构和含硝酸甘油的组合物。矫形支撑结构为受损组织提供机械支撑，并使含硝酸甘油的组合物与使用该系统的受试者的皮肤接触。含硝酸甘油的组合物可以整合到整形外科支持结构中，或者支持结构可被配置成含有可除去剂量的含有硝酸甘油的组合物。该系统和方法提供减轻疼痛和改善肌肉骨骼组织的功能。

4. 发明申请

WO2007143185A3 TRANSDERMAL TREATMENT OF TENDINOPATHY USING GLYCERYL TRINITRITE 审中-公开
标题翻译：使用谷氨酸TRINITRITE的TENDINOPATHY的透皮治疗
公开(公告)号：WO2007143185A3
公开(公告)日：2008-06-26
申请号：PCT/US2007013117
申请日：2007-06-01
申请人： CURE THERAPEUTICS INC , MURRELL GEORGY ANTHONY CALVERT , ANG ROBERT , WEIMANN LUDWIG , JACOBSON SVEN
发明人： MURRELL GEORGY ANTHONY CALVERT , ANG ROBERT , WEIMANN LUDWIG , JACOBSON SVEN
IPC分类号： A61F13/00 , A61K31/21
CPC分类号： A61K9/0014 , A61K9/7023 , A61K31/21
摘要： The present invention provides methods for treating tendinopathy providing a durability of effect by administering nitroglycerin. Such methods include methods for relieving pain associated with such tendinopathies. The use of a transdermal patch configured to deliver glyceryl trinitrate at a rate of 5 mcg/hr to about 85 mcg/hr.
摘要翻译：本发明提供通过施用硝酸甘油来治疗提供耐久性的腱鞘的方法。这些方法包括减轻与这种腱病相关的疼痛的方法。使用透皮贴片，其配置为以5mcg / hr的速率将硝酸甘油酯输送至约85mcg / hr。

5. 发明申请

WO2008046014A1 TREATMENT OF ALZHEIMER'S DISEASE USING COMPOUNDS THAT REDUCE THE ACTIVITY OF NON-SELECTIVE CA++- ACTIVATED ATP-SENSITIVE CATION CHANNELS REGULATED BY SUR1 RECEPTORS 审中-公开
标题翻译：使用化合物治疗ALZHEIMER的疾病，降低由SUR1受体调节的非选择性CA ++活化的ATP敏感通道的活性
公开(公告)号：WO2008046014A1
公开(公告)日：2008-04-17
申请号：PCT/US2007/081128
申请日：2007-10-11
申请人： REMEDY PHARMACEUTICALS, INC. , JACOBSON, Sven , ANG, Robert
发明人： JACOBSON, Sven , ANG, Robert
IPC分类号： A01N47/34 , A61K31/175
CPC分类号： A61K31/175
摘要： NSC antagonists are disclosed as useful in the treatment of dementia, in delaying the onset of dementia, and in the prevention of dementia. Dementia so treated may be, for example, Alzheimer's Disease (AD). NSC antagonists for treating dementia such as AD may be administered alone, a) in combination with other drugs used for treating dementia, b) in combination with drugs that stabilize or increase blood plasma glucose levels, or with both a) and b). Pharmaceutical compositions, dosage forms, and methods for using the same are disclosed, which include NSC antagonists, NSC antagonists combined with dementia drugs, NSC antagonists combined with glucose-level stabilizing or enhancing drugs, or combinations of these. Dosage forms may be designed to provide stable plasma levels for extended periods of time. Exemplary pharmaceutical compositions include compositions including glibenclamide and memantine; glibenclamide and donepezil; tolbutamide and memantine; tolbutamide and donepezil; and these compositions further including glucagon and/or glucose.
摘要翻译：公开了用于治疗痴呆，延缓痴呆发病以及预防痴呆的NSC拮抗剂。如此治疗的痴呆可以是例如阿尔茨海默病（AD）。用于治疗痴呆症如AD的NSC拮抗剂可以单独施用，a）与用于治疗痴呆的其他药物组合，b）与稳定或增加血浆葡萄糖水平的药物组合，或同时使用a）和b）。公开了药物组合物，剂型和使用该组合物的方法，其包括NSC拮抗剂，与痴呆药物联合的NSC拮抗剂，与葡萄糖水平稳定化或增强药物联合的NSC拮抗剂或它们的组合。剂量形式可以设计成在长时间内提供稳定的血浆水平。示例性药物组合物包括组合物，包括格列本脲和美金刚; 格列本脲和多奈哌齐; 甲苯磺丁脲和美金刚; 甲苯磺丁脲和多奈哌齐; 并且这些组合物还包括胰高血糖素和/或葡萄糖。

6. 发明申请

WO2007092284A3 LOW DOSE NO DONOR-CONTAINING TRANSDERMAL PATCH 审中-公开
标题翻译：低剂量不含复合透皮贴片
公开(公告)号：WO2007092284A3
公开(公告)日：2008-07-03
申请号：PCT/US2007002835
申请日：2007-02-02
申请人： CURE THERAPEUCTICS INC , ANG ROBERT , JACOBSON SVEN , WEIMANN LUDWIG
发明人： ANG ROBERT , JACOBSON SVEN , WEIMANN LUDWIG
IPC分类号： A61F13/02 , A61F13/00
CPC分类号： A61K9/7061 , A61K31/21 , A61K47/10
摘要： The present invention is drawn to a transdermal patch for the delivery of a nitroglycerin or other NO donor. The patch can comprise a backing layer, and a nitroglycerin-containing composition or other NO donor-containing composition which is supported at least in part by the backing layer. The transdermal patch can have a drug delivery zone defined by the area where the composition contacts an intact human skin site, and the transdermal patch can be formulated to deliver a nitric oxide donor, such as nitroglycerin, at from about 5 µg/hour to about 70 µg/hour. In one embodiment, the transdermal patch can provide a delivery rate at the drug delivery zone of from about 1 µg/cm2/day to about 600 µg/cm2/day. In another embodiment, the transdermal patch can contain from 6 wt% to 18 wt% of the nitric oxide donor, e.g., nitroglycerin. In each embodiment, the patch can contain at least 450 µg/cm2 of nitroglycerin.
摘要翻译：本发明涉及用于递送硝酸甘油或其他NO供体的透皮贴片。贴剂可以包含背衬层和含硝酸甘油的组合物或至少部分由背衬层支撑的含NO供体的组合物。透皮贴剂可以具有由组合物接触完整的人皮肤部位的区域限定的药物递送区，并且透皮贴剂可以配制成以约5μg/小时至约约1μg/小时递送一氧化氮供体，例如硝酸甘油 70μg/小时。在一个实施方案中，透皮贴剂可以在药物递送区域提供约1μg/ cm 2 /天至约600μg/ cm 2 /天的递送速率。在另一个实施方案中，透皮贴剂可含有6重量％至18重量％的一氧化氮供体，例如硝酸甘油。在每个实施方案中，贴剂可含有至少450μg/ cm 2的硝酸甘油。

7. 发明申请

WO2007046850A3 VASCULAR ACCESS 审中-公开
标题翻译：血管通路
公开(公告)号：WO2007046850A3
公开(公告)日：2008-01-10
申请号：PCT/US2006011624
申请日：2006-03-30
申请人： ACCESS SCIENTIFIC INC , TAL MICHAEL , MARANO JOHN P JR , FLOM JAMES R , LAPETINA JOHN F , ANG ROBERT YUEN LEE , ABROFF AARON , GANDARILLAS CARL , WEI MICHAEL F , DRUKER JOSHUA , ANDERSON JANELLE
发明人： TAL MICHAEL , MARANO JOHN P JR , FLOM JAMES R , LAPETINA JOHN F , ANG ROBERT YUEN LEE , ABROFF AARON , GANDARILLAS CARL , WEI MICHAEL F , DRUKER JOSHUA , ANDERSON JANELLE
IPC分类号： A61M29/00
CPC分类号： A61M25/0606 , A61M25/0097 , A61M25/0618 , A61M29/00 , A61M2025/0687
摘要： A device may include a hollow needle, a dilator mounted coaxially on the needle, and a sheath mounted coaxially on the dilator. The dilator may be slideably displaceable relative to the sheath.
摘要翻译：装置可以包括中空针，同轴地安装在针上的扩张器，以及同轴地安装在扩张器上的护套。扩张器可以相对于护套可滑动地移位。

8. 发明申请

WO2007046850A2 VASCULAR ACCESS 审中-公开
标题翻译：血管通路
公开(公告)号：WO2007046850A2
公开(公告)日：2007-04-26
申请号：PCT/US2006/011624
申请日：2006-03-30
申请人： ACCESS SCIENTIFIC, INC. , TAL, Michael , MARANO, John, P., Jr. , FLOM, James, R. , LAPETINA, John, F. , ANG, Robert, Yuen Lee , ABROFF, Aaron , GANDARILLAS, Carl , WEI, Michael, F. , DRUKER, Joshua , ANDERSON, Janelle
发明人： TAL, Michael , MARANO, John, P., Jr. , FLOM, James, R. , LAPETINA, John, F. , ANG, Robert, Yuen Lee , ABROFF, Aaron , GANDARILLAS, Carl , WEI, Michael, F. , DRUKER, Joshua , ANDERSON, Janelle
IPC分类号： A61B17/125
CPC分类号： A61M25/0606 , A61M25/0097 , A61M25/0618 , A61M29/00 , A61M2025/0687
摘要： A device may include a hollow needle, a dilator mounted coaxially on the needle, and a sheath mounted coaxially on the dilator. The dilator may be slideably displaceable relative to the sheath.
摘要翻译：装置可以包括中空针，同轴地安装在针上的扩张器，以及同轴地安装在扩张器上的护套。扩张器可以相对于护套可滑动地移位。

9. 发明申请

WO2007124110A2 VASODIALATING DRESSING FOR USE WITH INTRAVENOUS CATHETERS 审中-公开
标题翻译： VASODIALATING DRESSING用于内窥镜
公开(公告)号：WO2007124110A2
公开(公告)日：2007-11-01
申请号：PCT/US2007/009756
申请日：2007-04-19
申请人： CURE THERAPEUTICS, INC. , ANG, Robert , GELIEBTER, David
发明人： ANG, Robert , GELIEBTER, David
IPC分类号： A61L15/00 , A61K31/21
CPC分类号： A61L15/44 , A61K31/21 , A61L15/58 , A61L2300/204 , A61L2300/40 , A61L2300/602
摘要： The present invention is drawn to adhesive dressings and associated systems and methods for use in reducing the occurrence of phlebitis and extending the lifespan of intravenous catheters. The adhesive dressings can include a backing layer, and a nitroglycerin-containing composition supported at least in part by the backing layer. The adhesive dressing can have a drug delivery zone defined by the area where the nitroglycerin-containing composition contacts an intact human skin site. The drug delivery zone can have an area of at least 2.5 cm 2 and can be configured such that when the adhesive dressing is applied to secure an intravenous catheter the drug delivery zone substantially overlays a vessel in which the intravenous catheter is inserted. The nitroglycerin-containing composition can be formulated to deliver nitroglycerin at from about 5 μg/hour to about 80 μg/hour.
摘要翻译：本发明涉及用于减少静脉炎发生并延长静脉内导管的寿命的粘合剂敷料和相关系统和方法。粘合剂敷料可以包括背衬层和至少部分由背衬层支撑的含有硝酸甘油的组合物。粘合敷料可以具有由含硝酸甘油的组合物接触完整的人皮肤部位的区域限定的药物递送区域。药物递送区可以具有至少2.5cm 2的面积，并且可以被配置为使得当施加粘合剂敷料以固定静脉内导管时，药物递送区基本上覆盖其中静脉内插入导管。含硝酸甘油的组合物可配制成以约5μg/小时至约80μg/小时递送硝酸甘油。

10. 发明申请

WO2007103190A2 TRANSDERMAL PATCH CONTAINING TRANSDERMAL NITRIC OXIDE-GENERATING AGENT FOR TREATING OVERUSE TENDINOPATHY 审中-公开
标题翻译：包含超氧化氮氧化物发生剂用于治疗过敏性TENDINOPATHY的透皮贴剂
公开(公告)号：WO2007103190A2
公开(公告)日：2007-09-13
申请号：PCT/US2007/005394
申请日：2007-02-28
申请人： CURE THERAPEUTICS, INC. , MURRELL, George, Anthony, Calvert , ANG, Robert , WEIMMAN, Ludwig , JACOBSON, Sven
发明人： MURRELL, George, Anthony, Calvert , ANG, Robert , WEIMMAN, Ludwig , JACOBSON, Sven
IPC分类号： A61K31/21 , A61K9/70
CPC分类号： A61K9/7023 , A61K31/21
摘要： The present invention provides methods for treating tendinopathy in the absence of inflammation by the transdermal administration of nitroglycerin. Such methods include methods for relieving pain associated with such tendinopathies. and the use of a transdermal patch configured to deliver glyceryl trinitrate at a rate of 5 mcg/hr to about 85 mcg/hr.
摘要翻译：本发明提供了通过透皮给药硝酸甘油来治疗不存在炎症的腱鞘炎的方法。这些方法包括减轻与这种腱病相关的疼痛的方法。以及使用透皮贴片，其被配置成以5mcg / hr的速率递送硝酸甘油酯至约85mcg / hr。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式